Ke Wang

机构：Zhejiang Chinese Medical University, Yanbian University, First People's Hospital of Yunnan Province, The First Hospital of Kunming, Chengdu University of Traditional Chinese Medicine · ORCID：0000-0002-2824-1047

发表论文 463 篇 · 总被引 10504 次 · h-index 50

代表论文

• Bounded rational decision-making modeling and analysis in local energy markets: A state-of-the-art review (2025 · Renewable and Sustainable Energy Reviews · 被引 47)
• Tislelizumab (anti-PD-1) plus chemotherapy as neoadjuvant therapy for patients with stage IB3/IIA2 cervical cancer (NATIC): a prospective, single-arm, phase II study (2025 · Signal Transduction and Targeted Therapy · 被引 15)
• BAY11-7082 Targets RNF25 to Reverse TRIP4 Ubiquitination-dependent NF-κB Activation and Apoptosis Resistance in Renal Cell Carcinoma (2025 · International Journal of Biological Sciences · 被引 11)
• Glucagon-like peptide-1 receptor agonist-induced cholecystitis and cholelithiasis: a real-world pharmacovigilance analysis using the FAERS database (2025 · Frontiers in Pharmacology · 被引 9)
• Immunotherapy in EGFR-mutant non-small cell lung cancer (2025 · Clinical and Experimental Medicine · 被引 5)
• Molecular mechanisms governing the differentiation and expansion of myeloid-derived suppressor cells (2025 · Frontiers in Cell and Developmental Biology · 被引 5)